Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cytokine-induced Killer Cells”

104 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 104 results

Post-approval studies (Phase 4)UnknownNCT01758679
What this trial is testing

A Clinical Trail of Iodine[131I] Metuximab Injection With CIK Cells for Preventing Hepatocellular Carcinoma

Who this might be right for
Multiple Drug Use
Tianjin Medical University Cancer Institute and Hospital 120
Large-scale testing (Phase 3)Study completedNCT01631357
What this trial is testing

Study of Chemotherapy Combination With Autologous Cytokine-Induced Killer Cell Immunotherapy to Treat Lung Cancer

Who this might be right for
Non-small Cell Lung CancerSquamous Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital 96
Testing effectiveness (Phase 2)Active Not RecruitingNCT02782546
What this trial is testing

Cytokine Induced Memory-like NK Cell Adoptive Therapy After Haploidentical Donor Hematopoietic Cell Transplantation

Who this might be right for
Acute Myeloid Leukemia
Washington University School of Medicine 60
Early research (Phase 1)Study completedNCT00477035
What this trial is testing

Post-transplant Autologous Cytokine-induced Killer (CIK) Cells for Treatment of High Risk Hematologic Malignancies

Who this might be right for
LeukemiaMultiple Myeloma
Sally Arai 22
Testing effectiveness (Phase 2)Study completedNCT03068819
What this trial is testing

Cytokine Induced Memory-like NK Cell Adoptive Therapy for Relapsed AML After Allogeneic Hematopoietic Cell Transplant

Who this might be right for
Acute Myeloid Leukemia
Washington University School of Medicine 62
Testing effectiveness (Phase 2)UnknownNCT00862303
What this trial is testing

DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating Patients With Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Fuzhou General Hospital 100
Testing effectiveness (Phase 2)UnknownNCT05108077
What this trial is testing

Treatment of Metastatic Tumors of the Urogenital Area With Cytokine-induced Killer Cells

Who this might be right for
Bladder CancerRenal Cancer
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus 20
Testing effectiveness (Phase 2)UnknownNCT01235845
What this trial is testing

Dendritic Cell (DC) Activated Cytokine-induced Killer Cell (DCIK) Combined With DC Treatment for Glioma

Who this might be right for
Malignant Glioma
Qingdao University 30
Testing effectiveness (Phase 2)Looking for participantsNCT05580601
What this trial is testing

Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Children's Hospital Medical Center, Cincinnati 20
Testing effectiveness (Phase 2)Study completedNCT01894373
What this trial is testing

Autologous Cytokine Induced Killer Cells (CIK) for Patients With Severe Psoriasis

Who this might be right for
PsoriasisAdoptive Immunotherapy
Chinese PLA General Hospital 10
Large-scale testing (Phase 3)Study completedNCT00769106
What this trial is testing

Study of Cytokine-induced Killer Cell (CIK) Treatment in Patients After Resection of Liver Cancer

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 200
Testing effectiveness (Phase 2)UnknownNCT01821495
What this trial is testing

Study of DC-CIK to Treat NPC

Who this might be right for
Nasopharyngeal Carcinoma
Guangxi Medical University 100
Testing effectiveness (Phase 2)UnknownNCT02688686
What this trial is testing

Safety and Efficacy of DC-CIK in Patients With Advanced Non-Small-Cell Lung Cancer With Bone Metastases

Who this might be right for
Non-Small-Cell Lung Cancer With Bone Metastases
Affiliated Hospital to Academy of Military Medical Sciences 30
Testing effectiveness (Phase 2)Study completedNCT01392989
What this trial is testing

Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders

Who this might be right for
Neural Tube DefectsAnemiaLeukemia, Myeloid+3 more
Everett Meyer 44
Not applicableUnknownNCT01498055
What this trial is testing

Autologous CIK Cells Infusion for the Treatment of Lung Cancer: a Randomized Controlled Study

Who this might be right for
Lung Cancer
Third Military Medical University 120
Testing effectiveness (Phase 2)Study completedNCT03190811
What this trial is testing

Anti-PD-1 Alone or Combined With Autologous DC-CIK Cell Therapy in Advanced Solid Tumors

Who this might be right for
Neoplasms
Capital Medical University 100
Testing effectiveness (Phase 2)UnknownNCT03124498
What this trial is testing

Evaluate Autologous CIK Cells in Patients With Hepatocellular Carcinoma After TACE, PEIT or RFA

Who this might be right for
Hepatocellular Carcinoma
Chuan An Biotechnology Co., Ltd. 55
Post-approval studies (Phase 4)Study completedNCT03084809
What this trial is testing

Chemotherapy Combined With CIK Treating Colon Cancer

Who this might be right for
Colorectal CancerCytokine-induced Killer CellsPostoperative Complications+1 more
China Meitan General Hospital 46
Testing effectiveness (Phase 2)UnknownNCT02202928
What this trial is testing

Adoptive Cell Therapy Plus Chemotherapy and Radiation After Surgery in Treating Patients With Colorectal Cancer

Who this might be right for
Colorectal CancerNeoplasmsIntestinal Neoplasms+2 more
Shenzhen Hornetcorn Bio-technology Company, LTD 60
Testing effectiveness (Phase 2)Enrolling By InvitationNCT01868490
What this trial is testing

The Adoptive Immunotherapy for Solid Tumors Using Modified Autologous CIK Cells

Who this might be right for
CholangiocarcinomaNeuroblastoma
Siriraj Hospital 20
Next Page